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Abstract
Background: Recent studies have suggested that bacteria associated with the placenta—a “placental
microbiome”—may be important in reproductive health and disease. However, a challenge in working with
specimens with low bacterial biomass, such as placental samples, is that some or all of the bacterial DNA
may derive from contamination in dust or commercial reagents. To investigate this, we compared placental
samples from healthy deliveries to a matched set of contamination controls, as well as to oral and vaginal
samples from the same women.
Results: We quantified total 16S rRNA gene copies using quantitative PCR and found that placental samples
and negative controls contained low and indistinguishable copy numbers. Oral and vaginal swab samples, in
contrast, showed higher copy numbers. We carried out 16S rRNA gene sequencing and community analysis
and found no separation between communities from placental samples and contamination controls, though
oral and vaginal samples showed characteristic, distinctive composition. Two different DNA purification methods were
compared with similar conclusions, though the composition of the contamination background differed. Authentically
present microbiota should yield mostly similar results regardless of the purification method used—this was seen for
oral samples, but no placental bacterial lineages were (1) shared between extraction methods, (2) present at >1 % of
the total, and (3) present at greater abundance in placental samples than contamination controls.
Conclusions: We conclude that for this sample set, using the methods described, we could not distinguish between
placental samples and contamination introduced during DNA purification.
Keywords: Placenta, Microbiome, 16S rRNA gene, Low biomass samples, Reagent contamination
Background
The placenta is a known reservoir for microbes that can
lead to adverse pregnancy outcomes (reviewed in [1] and
[2]). However, the concept of commensal microbial com-
munities that could become dysbiotic and induce pla-
cental dysfunction, leading to adverse outcome, has not
been established. Several recent studies introduced the
idea that the healthy human placenta harbors a unique
low-abundance microbiome [3–6]. Tracking of lineages
enriched in the placental samples suggested a possible
oral origin [3]. These data were intriguing, potentially
paralleling published imaging studies suggesting detection
of intracellular bacteria in the basal plate of placentas at
the maternal-fetal interface [7, 8]. However, studies of low
biomass samples such as placenta are known to be ex-
ceedingly difficult. When low amounts of bacteria are
present in a sample, contaminating sources of bacterial
DNA can predominate, such that sequences recovered
may contain mostly contamination from dust, commercial
reagents, or other sources [9, 10]. In the report of a com-
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control studies was reported, leaving the possible contri-
bution of contamination unclear.
Given our interest in microbial infection and preterm
birth, we sought to carry out a comprehensive study of pla-
cental samples to evaluate possible microbial colonization
and to provide a platform for future research. Because our
focus was on issues of sampling and contamination, we
analyzed an extensive set of matched experimental and
control samples (7 samples per subject, plus additional
contamination controls) for six subjects. Placental tissue
was harvested from the basal plate and the fetal side of the
placenta using a uniform protocol. These placental sam-
ples were compared to blank swabs waved in air in the
clinical laboratory where placental samples were processed,
unused sterile swabs, and DNA purifications with no
added starting material. We also compared oral and va-
ginal samples from the same women obtained at admis-
sion to the hospital for delivery. We used real-time
quantitative polymerase chain reaction (qPCR) for ab-
solute quantification of bacterial sequence abundance
and 16S rRNA gene tag sequencing to quantify commu-
nity composition. Two different methods for DNA
purification were compared, because low-level contam-
ination has been reported to derive from commercial
kits [9–11]. In both assays (qPCR and 16S rRNA gene
tag sequencing), placental samples could not be distin-
guished from background contamination controls.
Results
Sampling strategy
Six women were selected for study with uncomplicated
singleton pregnancies at term in spontaneous labor (regu-
lar contractions, cervical dilation) or following spontan-
eous rupture of membranes. Demographic and clinical
characteristics of participants are listed in Additional file 1:
Table S1. Sample types collected are listed in Table 1.
Placental samples were isolated as 0.5 × 0.5 × 0.5 cm
cuboidal sections from internal structures within the
placenta (maternal and fetal sides) to eliminate surface
contamination. Maternal saliva samples and vaginal swab
samples were also collected by study personnel from par-
ticipants at admission to the hospital preceding delivery.
Analysis of paired samples from the same patient is a
notable difference from [3], where non-placental samples
(vaginal/oral) were from historical controls.
Three types of negative controls were collected. Follow-
ing each delivery, a swab was waved in the air in the clin-
ical laboratory where the placental biopsies were carried
out (adjacent to the labor and delivery rooms), then sealed
in a closed container (designated “air swab”). Unused sterile
swabs were also collected (“sterile swab”). Thirdly, samples
containing the purification reagents only were purified by
each method to document bacterial sequences introduced
during downstream sample processing (“extraction blank”).
DNA was then purified from each specimen. Two dif-
ferent kits were compared, the STRATEC PSP Spin
Stool DNA Plus Kit (henceforth “PSP”) and the MO BIO
PowerSoil DNA Isolation Kit (abbreviated “MO BIO”),
both of which have been used extensively in microbiome
research, and the second of which was used by Aagaard
et al. [3], which proposed the existence of a commensal
microbiota. An additional reason for comparing these two
methods is to identify reagent contamination, because
contaminating 16S rRNA gene sequences introduced by
DNA purification kits tend to differ by kit [9, 10].
Analysis of total 16S rRNA gene copies using quantitative
PCR
Quantification of 16S rRNA gene copies by quantitative
PCR is shown in Fig. 1a, b. For qPCR, equal volumes of
the purified DNA of all samples were used in the assay.
In this and subsequent figures, results for DNA samples
prepared using the two purification kits are shown side
by side. For the PSP kit, the mean 16S rRNA gene copies
in the saliva samples were 2.3 × 107 ± 1.42 × 107 SEM
(standard error of the mean). Mean copy number in the
vaginal samples was 5.97 × 106 ± 2.92 × 106 SEM. Results
for placental samples were much lower, with mean copy
number for maternal side (MS) at 5.72 × 102 ± 3.48 × 102
SEM and fetal side (FS) at 1.24 × 102 ± 2.1 × 101 SEM.
For controls, the mean copy number was between 9.7 ×
101 ± 4.1 × 101 and 1.93 × 102 ± 3.07 × 101 SEM. For the
MO BIO kit, mean copy number for the saliva samples
was high, 3.69 × 108 ± 2.98 × 108 SEM, while mean copy
numbers for the placental samples were again much
lower and indistinguishable from contamination con-
trols; maternal side placenta was 2.56 × 102 ± 1.05 × 102
SEM, fetal side was 2.61 × 102 ± 6.3 × 101 SEM, and for
controls mean copy numbers were between 8.77 × 101 ±
1.1 × 101 SEM and 1.29 × 102 ± 2.87 × 101 SEM.
For statistical analysis, we compared the cycle of thresh-
old values for all sample sets, because this represents the
rawest form of the data (Fig. 1c, d; amplification curves in
Table 1 Sample types studied
Sample Collection protocol/comments
Air swab Swab of the air from the clinical laboratory where
the placental samples were obtained
Sterile swab Unopened sterile swab
Extraction blank Blank tubes for possible extraction/reagent
contaminants
Placenta (MS) Basal plate biopsy obtained after removal of
placental surface
Placenta (FS) Placental biopsy obtained after removal of
placental surface
Saliva Collected in sterile 50-mL conical tube
Vaginal swab Swab inserted into maternal vagina for 30 s
Lauder et al. Microbiome  (2016) 4:29 Page 2 of 11
Additional file 2: Figure S1). The cycle of threshold indi-
cates the value at which exponential increase in the fluor-
escence signal initiated, so larger values indicate lower
numbers of starting templates. For tests of samples puri-
fied using either method, there was no significant differ-
ence between median values for any pair of placental and
control samples (p > 0.05; Kruskal-Wallis test with Dunn’s
post test). In comparisons without correction for multiple
comparisons, one pair showed a difference in the direction
of the negative control air swab amplifying at lower cycle
of threshold (more template copies) than the fetal side
placental sample (Fig. 1c).
Using a Bayesian approach, it is possible to interrogate
these data further (Additional file 3: Figure S2). A pos-
terior probability distribution was calculated for the dif-
ference in mean cycle numbers between air swabs and
all other sample types. Based on the posterior probability
distribution, we calculated that for both placental sam-
ples extracted by either of the methods, comparison to
air swabs yielded p > 0.05 for the probability of greater
abundance of 16S rRNA gene DNA in the placental
samples, as was seen with conventional hypothesis test-
ing. Further, we calculate the probability that the pooled
placental samples contain 10-fold or more 16S rRNA
gene copies than air swabs as p = 0.00004 for PSP and
p = 0.004 for MO BIO. In addition, the analysis shows
that there is a 95 % probability that the placental
samples have <3.5× more DNA than air swabs in MO
BIO and <0.8× DNA for PSP. For comparison, the
vaginal or oral swabs have ~30,000-fold more DNA than
controls when compared by this method.
In summary, all placental and negative control samples
were at the extreme low end of the range detectable by
qPCR (Additional file 2: Figure S1A–C). For both purifi-
cation methods, we conclude that placental and control
samples showed low and indistinguishable numbers of
16S rRNA gene copies.
Analysis of bacterial community structure using deep
sequencing
Samples were next compared based on the proportions of
bacterial lineages in each specimen using deep sequen-
cing, investigating the hypothesis that the types of bacteria
present in placental and control samples differed. Samples
were pooled for sequencing by adding equal volumes of
the purified DNA from placental and control samples and
equal masses of DNA for the higher biomass oral and
vaginal samples.
DNA samples were PCR amplified using bar-coded
primers flanking the V1V2 region of the 16S rRNA gene,
and samples were sequenced using the Illumina method
(Fig. 2a, b). The V1V2 region is useful with low biomass
samples because the shorter length allows more efficient
amplification of rare template sequences, as shown, for
example, in studies of bronchoalveolar lavage samples
[11–15], and V1V2 has been used extensively in previous
work [16–18]. An alternative approach is to use shotgun
metagenomic sequencing to characterize all DNA present
a b
c d
Fig. 1 Quantitative PCR analysis of 16S rRNA gene copy numbers. 16S rRNA gene copies per reaction were quantified in the six study subjects
using (a) PSP extraction method and (b) MO BIO extraction method. Fetal side (FS), maternal side (MS). c, d Comparison of mean cycle threshold
values for 16S rRNA gene qPCR. Limit of detection is 38.29 (PSP) and 34.04 (MO BIO). All data sets were analyzed by Kruskal-Wallis with Dunn’s
post test. Comparison of any pair of placental samples to controls yielded p > 0.05
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Fig. 2 Heat maps illustrating the major bacterial lineages detected in each sample. Heat maps of major bacterial lineages for (a) PSP- and (b) MO
BIO-extracted samples. Columns indicate the patient ID and sample types, and rows indicate the OTU detected in sequencing. Fetal side (FS),
maternal side (MS), family (f), genus (g), order (o)
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in a sample [3]—however, this has the disadvantage for
placental samples that the great majority of the sequen-
cing effort is expended resequencing human DNA and so
provides little additional information at a much higher
cost when only a characterization of bacterial taxa present
is desired. Each sample returned an average of 59,198
(PSP extraction) and 25,044 (MO BIO extraction) 16S
rRNA gene reads. After forming operational taxonomic
units at 97 % identity, a total of 12,813 OTUs were recov-
ered for the PSP samples and 12,032 OTUs for the MO
BIO samples.
For the high biomass saliva samples, the major bacterial
lineages were consistent between the two DNA purifica-
tion methods. The saliva samples were high in Streptococ-
cus, Veillonella, and Prevotella, paralleling many previous
studies [11, 14, 19]. The lineages detected for samples
purified with each of the two methods were identical at
the OTU level.
Vaginal samples were collected as single swabs and thus
could be assayed with only one DNA purification method.
We chose PSP because it yielded particularly good DNA
recovery from other types of microbiome samples [20].
Vaginal samples were high in Lactobacillus, as has been
seen for vaginal samples in many studies [19, 21–23].
For the placental and background contamination sam-
ples, results diverged radically and were associated with
the kit used to purify the DNA. For samples purified
using the PSP kit, all placental samples and background
controls contained Sediminibacterium, Bradyrhizobiaceae,
Methylobacterium, and Propionibacterium. In most sam-
ples, the first three contributed the majority of the
sequence reads. Sediminibacterium, from the family
Sphingobacteriaceae, is a known soil bacterium. Bradyrhi-
zobiaceae contains both soil- and plant-associated bacteria
as well as animal-associated bacteria. Methylobacterium is
a normal inhabitant of soil and water. Propionibacterium
is a ubiquitous human skin organism that is common in
house dust. All four lineages have all been reported to be
common contaminants of DNA extraction kits [9, 10].
Additional lineages were prominent in a few samples.
One of the maternal side biopsy samples was high in
Enterobacteraceae and a second in Prevotella. Several
contamination controls were high in Phyllobacteriaceae,
another bacteria associated with soil and plants that
has been identified as a contaminant of DNA extrac-
tion kits [9, 10].
For DNA purified from the MO BIO kit, the dominant
lineage in the controls was an OTU aligning 100 % to
Clostridium difficile. This OTU was predominant in 22
out of 23 samples, including fetal side and maternal side
placenta, extraction blanks, unopened sterile swabs, and
swabs exposed to air in the clinical laboratory. This
OTU was found in a previous negative control sample
from our laboratory in another study extracted with this
kit, but not in negative control samples extracted with
other kits, suggestive of contamination in commercial
reagents. We have previously amplified C. difficile 16S
rRNA gene sequences in our laboratory, so we cannot
rule out that the low-level contamination originated
from this source. However, as C. difficile only appeared
in negative controls worked up with the MO BIO kit, we
tentatively associate this contamination with the kit.
Additionally, one sample was high in a lineage of the
order Streptophyta, possibly a sequence derived from
chloroplasts in pollen.
We attempted to investigate the origin of the sample-
specific high proportion OTUs in the maternal side placen-
tal data set but were unable to specify the source. Of
particular interest were connections with oral microbiota,
since oral sites were proposed to donate lineages to pla-
centa in the previous report on a commensal microbiome
by Aagaard and colleagues [3]. For the PSP-extracted sam-
ples, although Prevotella lineages could be detected in sub-
ject 67’s oral samples, the OTU enriched in the maternal
side placental biopsy was not among those present in the
subject’s saliva sample, nor in her vaginal or fetal side pla-
cental samples. Thus, the data did not support the idea that
the Prevotella detected in placenta originated at an oral
site. For the Enterobacteraceae OTU enriched in the ma-
ternal side sample from subject 61, no reads were detected
from this OTU in saliva or vaginal samples, and three
reads were detected for fetal side placental samples (out of
7633). Thus, we were unable to trace the origin of these
outlier lineages to specific body sites in our paired samples.
Analysis of clustering by sample type
We next compared community structure by calculating
distances between all pairs of samples and interrogating
these data for clustering associated with sample type. In
our first approach, we calculated Bray-Curtis distances
for data pooled at the phylum level, paralleling the ap-
proach used by Aagaard et al. [3]. For each purification
method, when all sample types were analyzed together,
the difference among groups was highly significant (PER-
MANOVA p < 0.001 for comparison of the centroids of
each group), driven by the formation of discrete clusters
for the vaginal and oral samples. The analysis was then
repeated, excluding the vaginal and saliva samples. In
this case, PERMANOVA p values were >0.05 for PSP-
extracted samples and 0.033 for MO BIO. The p value
lower than 0.05 in the MO BIO analysis could be attrib-
uted to outliers in the unopened sterile swab controls—-
comparison of placental samples to swabs exposed to air
in the clinical laboratory and extraction blanks only (drop-
ping out the unopened swabs) showed a p value of 0.11.
Thus, we conclude that we could not distinguish placental
samples from contamination controls by PERMANOVA
analysis of Bray-Curtis distances.
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We repeated the PERMANOVA tests using weighted
and unweighted UniFrac distances generated from
operational taxonomic units (OTUs) clustered at 97 %
sequence similarity, a more conventional approach
(Additional file 4: Figure S3A-H). Once again, there was
significant clustering by group when all groups were
analyzed together (p = 0.001 for both weighted and un-
weighted UniFrac). When the vaginal and salivary samples
were removed, p values were >0.05 for PSP-extracted sam-
ples and 0.024 and 0.049 for MO BIO (unweighted and
weighted, respectively). Paralleling the results of the Bray-
Curtis analysis, removal of the sterile swab data resulted
in p values >0.05 for use of both weighted and unweighted
UniFrac (comparing placental samples to air swabs and
extraction blanks). Thus, we conclude that we could not
distinguish placental samples from contamination controls
using UniFrac and PERMANOVA, though we could read-
ily distinguish oral and vaginal samples.
A heat map summarizing OTU representation in the
sample set is shown in Fig. 3. Clustering by resemblance
among samples pulled the oral samples together, with
pairs of samples from each of the six individuals cluster-
ing together despite purification using different DNA
purification kits. The placental samples and contamin-
ation controls were interspersed and mostly clustered by
the kit used for purification (27/28 for MO BIO and 28/
29 for PSP). The vaginal samples mostly clustered to-
gether (5/6) within the PSP group.
Fig. 3 Analysis of microbial communities by co-occurrence. The heat map compares taxa observed within each sample, where each row represents
a sample and each column an OTU. OTU sample combinations are colored to indicate abundance relative to the maximum proportion observed in
any sample for that OTU. Thus, the red cell in each column indicates the sample with the highest proportional abundance for that OTU. Sample
characteristics are given to the right of the plot and are color coded for convenience; numbers refer to the research subject ID. Row and
columns are clustered by co-occurrence with trees indicating complete-linkage clustering of the Euclidean distance between the abundances
of samples (rows) or OTUs (columns)
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Analysis of enriched lineages
We next asked whether any single lineages could be
extracted from the data that might represent authentic
placental microbiota. We reasoned that any lineages that
were seen in placental samples extracted by both methods,
but less abundant or absent in controls, would be candi-
dates (though we note that there is evidence for occasional
recovery of different lineages dependent on the DNA
purification kit used [24]).
An overview of OTU sharing between pairs of samples
extracted by the two methods is presented in Fig. 4,
summarizing the community recovered over a wide
range of abundance filters. Placental and salivary OTUs
were first filtered by requiring recovery in both the PSP
and MOBIO procedures, then the reproducible OTUs
were compared to contamination. In this method, a repro-
ducible OTU seen in placental or oral samples at a given
proportion was counted if absent in contamination con-
trols at or above that proportion. By this means, we scored
the placental or oral OTUs enriched over contamination
in comparisons spanning 5 logs of abundance values
(Additional file 5: Table S3).
There were no placental OTUs that achieved at least
1 % abundance in both PSP and MOBIO in at least one
sample and not in controls, In contrast, the same filtering
procedure recovered 28 OTUs from salivary samples.
Analyzing shared OTUs achieving 0.001 % in any sample,
we found that 2197 OTUs were recovered in the oral
samples, 16 in the maternal side placental samples, and 5
in the fetal side placental samples. Two OTUs appeared in
both fetal and maternal side samples, leaving 19 unique
placental OTUs. Of these OTUs, 16 OTUs were seen in
one placenta only and three were seen in multiple placen-
tas. The three OTUs found in multiple placentas could
not be assigned to any bacterial taxa, and further analysis
showed the sequences were 100 % identical to human
chromosomal sequences. Thus, focusing on the more
abundant OTUs, there were no OTUs that appear
reproducibly in the placental samples with proportional
abundance 1 % or higher that were not also present at the
same or higher levels in the contamination controls.
Discussion
Here, we compared bacterial DNA recovered from pla-
cental samples from six uncomplicated deliveries at term
(both fetal side and maternal side internal tissues) to
contamination controls. We assayed (1) the absolute
number of 16S rRNA gene copies and (2) overall com-
munity structure queried by deep sequencing of 16S
rRNA gene tags. In the qPCR analysis, both the placental
samples and contamination controls yielded quite low
values, with no clear signal in the placental samples
above negative controls. In the community analysis,
there was no clear separation of placental samples from
contamination controls based on PERMANOVA analysis
of the Bray-Curtis and UniFrac distances nor were any
placental-enriched lineages detected reproducibly that
were present as 1 % of the community or greater. Thus,
we were unable to detect any consistent differences be-
tween the placental samples and contamination controls.
We compared two DNA purification methods, which
helped to clarify the influence of contamination originat-
ing in the purification kits. Oral sites are known to host
dense bacterial communities, and similar lineages were
found in the oral samples regardless of the DNA purifi-
cation method used. Placental and contamination con-
trol samples, in contrast, harbor little or no detectable
bacterial DNA by QPCR; and for these samples, the bac-
terial lineages recovered were highly dependent on the
purification method used. Thus, these data suggest that
the predominant lineages observed in the placental and
control samples originated as contamination that dif-
fered between kits. Recent control studies from others
documented bacterial DNA contamination in DNA
purification kits and differences among manufacturers,
paralleling results here [9, 10].
We reasoned that authentic microbiota should be
mostly reproducible regardless of the DNA extraction
kit used and so focused on OTUs recovered in common
using both extraction kits from placental or saliva sam-
ples (Fig. 4). In our analysis, we also required that the
reproducible OTU be of greater proportional abundance
in placenta or saliva than in any control. In the saliva
Fig. 4 Enrichment of bacterial lineages detected reproducibly in
placental or oral samples. The number of OTUs present in at least one
saliva (red) or maternal (green) or fetal (blue) side fetal sample in both
DNA extractions and not in negative controls at that abundance is
shown over a range of abundance values (x-axis)
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samples, reproducible OTUs that met these criteria were
readily detected. When we interrogated placental sam-
ples, we found no reproducible OTUs that were above
1 % in abundance and also at less than 1 % abundance
in all contamination controls. At the lowest cut value,
0.001 % abundance, we found 18 OTUs reproducible
between extractions for the maternal side sample and 5
for the fetal side sample. Some of these extremely low-
abundance lineages may represent sporadic, rare placental
microbiota. However, at this low level of abundance, noise
is abundant in the data—several unclassified OTUs appar-
ently arose from mispriming on human DNA. It is
unlikely that we fully sampled all potential contaminants,
and apparently enriched lineages could be found readily in
comparisons between contamination data sets. Thus, an
alternative explanation for the remaining placental OTUs
is that they represent unsampled low-level contamination.
This study has several limitations. Our data do not
rule out the existence of placental microbiota—we can
only conclude that we could not use our data to distin-
guish placental samples from contamination controls.
There could potentially be placental microbiota that is
below our level of detection. We studied only six preg-
nancies, so it remains possible that with more subjects, a
signal might be detected; though we would predict that
detection would occur against a notable contamination
background. The 16S rRNA gene window we used
(V1V2) has biases in the lineages detected, as do all
metagenomic methods, so any placental bacteria not de-
tected by our amplification strategy would have been
missed. We did not attempt to study the surface of the
placenta due to likely issues with contamination during
delivery—a recent paper studied placental microbiota
specimens sampled near the surface of the placenta after
vaginal delivery and found the swabs to be rich in line-
ages common in vagina [25]. If there is patchy microbial
colonization, it might have gone undetected. Our data
also have no bearing on the question of whether the pla-
centa might be colonized in disease states because the
six mother-baby pairs studied were healthy.
We can make several recommendations for future
studies of placental microbiome samples and low bio-
mass samples in general. (1) At the start of a study that
might involve low biomass samples, it is essential to
carry out some form of absolute abundance measure
(here qPCR of total 16S rRNA gene copies) to determine
whether samples of interest are indeed of low biomass,
so that appropriate precautions can be taken. (2) When
working with low biomass samples, start with the null
hypothesis that all samples are contamination only and
ask whether this idea can be rejected with data. (3) It is
essential that contamination controls be generated and
analyzed contemporaneously with experimental samples.
Different DNA extraction kits are documented to have
different contaminants, and contamination may vary by
batch [9, 10]. Thus, comparison of unmatched samples
and controls may lead to spurious distinctions. (4) In our
hands, PCR amplification for library preparation some-
times does not yield detectable DNA by bulk measures
such as gel electrophoresis, but low numbers of sequence
reads can still be recovered—thus, it is important to se-
quence even libraries that appear to be failures in order
to sample the contamination background fully. (5) Post
hoc analysis, where the parent groups showed no global
difference, can be risky. Ideally, results from any such
analysis will be retested in an independent validation
cohort [26]. (6) It would be helpful if reviewers of
microbiome papers analyzing low biomass samples
consistently asked authors to report contamination
controls and their procedure for rejecting the hypothesis
that all samples contain contamination only.
Conclusions
We analyzed samples from oral, vaginal, and placental sites
from six deliveries of healthy babies. Although we could
readily detect distinctive microbial signatures in oral and
vaginal samples, we were unable to distinguish placental
samples from contamination controls using our data.
Methods
Human subjects studied
Patients were identified and enrolled as part of a large
case–control study (Cellular Injury and Preterm Birth,
CRIB) funded by the March of Dimes Prematurity Re-
search Center at the University of Pennsylvania. All
women in the current study were enrolled as term deliv-
ery controls in the CRIB study. Women were enrolled
after admission to the labor and delivery unit at the
Hospital of the University of Pennsylvania. The electronic
medical records of potential study participants were
screened by study coordinators to determine eligibility.
Women aged 18–45 years with singleton pregnancies who
were admitted to the hospital with spontaneous labor
(regular contractions, cervical dilation) or premature rup-
ture of membranes (PROM) and delivered at term (380/7
to 416/7 weeks gestational age) were eligible for enrollment
as controls in the CRIB study. Exclusion criteria for
controls were multiple gestation, fetal chromosomal
abnormality, major fetal anomaly, intra-uterine fetal
demise, intra-uterine growth restriction, gestational
hypertension/preeclampsia, clinical chorioamnionitis,
induction of labor, and elective cesarean delivery. To
date, more than 100 women have been enrolled and
samples collected for the CRIB study. We selected
sample sets from six controls at random for the current
study. The CRIB study has been approved by the Insti-
tutional Review Board at the University of Pennsylvania
(protocol #821376).
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Sample collection protocol
Maternal saliva and vaginal samples were collected from
participants after enrollment into the CRIB study. Placental
samples were collected following delivery.
Maternal saliva samples were collected in sterile 50-
mL conical tubes labeled with the participants’ study ID
numbers. Each participant was asked to allow saliva to
collect in her mouth for 1 min, after which she spit into
the 50-mL tube. The tube was capped by the clinical
research coordinator and placed immediately at −20 °C
before transfer within 48 h to a −80 °C freezer for storage.
In order to collect vaginal samples from study partici-
pants, trained clinical research coordinators performed a
sterile speculum examination and inserted a labeled
ESwab (Copan Diagnostics, Murrieta, CA) approximately
2 in. into the patient’s vagina, swirling the swab for 30 s
making sure to contact the walls of the vagina so that the
swab could absorb cervicovaginal fluid. ESwab is a liquid-
based multipurpose collection and transport system that
maintains viability of aerobic, anaerobic, and fastidious
bacteria for up to 48 h at room and refrigerator
temperature. The ESwabs were stored in collection tubes
provided by the manufacturer at 4 °C and then moved to
long-term storage at −20 °C.
Following delivery, placentas were placed in sterile
containers on ice and transported by clinical research
coordinators to the clinical laboratory located adjacent
to the labor and delivery rooms at the Hospital of the
University of Pennsylvania. Coordinators were trained by
one of the principal investigators (SP) for the March of
Dimes Prematurity Research Center at the University of
Pennsylvania, and coordinators wore masks and sterile
gloves during the placental dissections. A total of six 0.5 ×
0.5 × 0.5 cm placental biopsies were obtained from each
placenta—three from the maternal side of the placenta
(basal plate), two from the fetal side, and one from the
mid-placental region. Placental biopsies were obtained
using established protocols that were modified slightly for
the purposes of the CRIB study [3, 27, 28]. Before obtain-
ing the placental biopsies, a sterile scalpel and forceps
were used to take off the maternal surface of placenta
(0.25–0.5-cm depth) in order to remove potential contam-
inants for microbiome studies. Biopsies were then ob-
tained by sharp dissection from a region equidistant from
the umbilical cord insertion site and the lateral edge of the
placenta [27, 28]. Three maternal side biopsies (basal
plate) were obtained first, then the mid-placental biopsy,
and then the two fetal side biopsies. Each biopsy sample
was rinsed in sterile phosphate-buffered saline, placed in a
sterile, labeled cryovial, flash-frozen in liquid nitrogen,
and stored at −80 °C. One maternal side biopsy sample
and one fetal side biopsy sample were selected randomly
for DNA purification by both of the methods for each of
the six participants in the current study.
DNA preparation
Method 1
DNA was isolated from placental biopsies, vaginal swabs,
saliva, and controls using the PSP Stool DNA Plus kit
(STRATEC Biomedical, Berlin-Buch, Germany) in a ster-
ile class II laminar flow hood. In this sample set, air
swabs of the clinical laboratory were matched to each
patient and the associated samples. Swab tips were cut
directly into bead tubes. The entirety of each tissue bi-
opsy was placed into a tared bead tube and weighed
(samples ranged from 0.11 to 0.48 g). One-hundred mi-
croliters of each saliva sample was used for DNA extrac-
tion. Lysing Matrix E tubes (MP Biomedical, Santa Ana,
CA) and a bead beating protocol were used instead of
the homogenization and pre-lysis procedure of the man-
ufacturer’s protocol. Samples were beaten for 20 min
with the PSP kit Stool DNA Stabilizer buffer using the
TissueLyser II (Qiagen, Hilden, Germany). Samples were
then incubated at 95 °C for 15 min, and DNA was ex-
tracted per manufacturer’s protocol. Extracted DNA was
stored at −20 °C.
Method 2
DNA was isolated from replicate biopsies, saliva, and
control samples using the MO BIO PowerSoil DNA
Isolation Kit (MO BIO Laboratories, Carlsbad, CA) in a
sterile class II laminar flow hood. Swab tips were cut dir-
ectly into bead tubes. The entirety of each tissue biopsy
was placed into a tared bead tube and weighed (samples
ranged from 0.12 to 0.66 g). Seventy to 100 μL of each
saliva sample was used for DNA extraction. Samples
were incubated at 70 °C for 10 min and homogenized
for 35 min on the TissueLyser II. DNA was then
extracted per manufacturer’s protocol. Extracted DNA
was stored at −20 ° C.
Quantification of 16S rRNA gene copies using qPCR
Bacterial DNA abundance was quantified by quantitative
PCR (qPCR) amplification of the V1V2 region of the 16S
rRNA gene. qPCR reactions were performed in triplicate
(25 μL each), using 1:2 dilutions of DNA template. Primer
and probe sequences and amplification conditions are
described in Additional file 6: Table S2 and [29, 30].
PCR amplification of the VIV2 region of bacterial 16S
rRNA gene for Illumina sequence analysis
For each sample, the 16S rRNA gene was amplified
using Golay-barcoded universal primers 27F and 338R
[31, 32], listed in Additional file 6: Table S2. PCR reac-
tions were carried out in quadruplicate (25 μL each)
with AccuPrime Taq DNA Polymerase High Fidelity
(Thermo Fisher Scientific Inc, Waltham, MA) with the
following recipe: 7.21 μL PCR-grade water, 2.5 μL 10×
buffer II, 0.19 μL Taq, 5 μL each forward and reverse
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primer (2 μM), and 5 μL template DNA. PCR reactions
were prepared in a PCR clean room. Reactions were run
on an Applied Biosystems GeneAmp PCR System 9700
(Thermo Fisher Scientific Inc, Waltham, MA) with the
following cycling conditions: initial denaturation at 95 °C
for 5 min followed by 30 cycles of denaturation at 95 °C
for 30 s, annealing at 56 °C for 30 s, and extension at
72 °C for 90 s, with a final extension of 8 min at 72 °C.
Replicate amplicons were pooled and bead purified using
Agencourt AMPure XP (Beckman Coulter, Indianapolis,
IN) with the manufacturer’s protocol. Reaction products
were sequenced using the Illumina MiSeq technology [33].
16S rRNA gene sequence analysis
The 16S rRNA gene reads were analyzed using the QIIME
software package [34] with default parameters augmented
by the package qiimer (github.com/kylebittinger/qiimer)
and the R programming language [35, 36]. Reads were re-
moved from the analysis if they did not match a 12-base
Golay barcode with 1 or fewer errors, if the paired reads
failed to overlap by 35 bases, if the overlapped region dif-
fered by more than 15 %, or if they had more than 3 base
calls below Q20. Operational taxonomic units (OTUs)
were created by clustering the reads at 97 % identity using
UCLUST [37]. Representative sequences from each OTU
were aligned using PyNAST [38], and a phylogenetic tree
was inferred using FastTree v. 2.1.3 [38, 39] after applying
the standard Lane mask for 16S rRNA gene sequences
[40]. Pairwise UniFrac distances were computed using
QIIME [41], and permutational tests of distance were per-
formed using the vegan library for the R programming
language [42]. Principal coordinates analyses were per-
formed with the APE library for R [43]. Taxonomic assign-
ments were generated by the UCLUST consensus method
of QIIME 1.8 [44], using the GreenGenes 16S rRNA gene
database v. 13_8 [45]. Bayesian analysis of qPCR data was
performed using the R library BEST [46].
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